Synthesis, in silico studies and in vitro cytotoxicity evaluation of novel posaconazole derivative as a ALK TK inhibitor

Oncology research progresses, yet cancer remains the largest medical need. The use of a medication with an accessible lead molecule shows great potential for long-term cancer therapy. It may help target cancer therapy and drug resistance. This work uses FDA-approved, clinically proven compounds to b...

Full description

Bibliographic Details
Main Authors: Rahul D. Jawarkar, Praveen Sharma, Sachin Jain, Umang Shah, Magdi EA Zaki, Sami A Al-Hussain, Suraj Mali, Chin-Hung Lai, Vijay H. Masand, Vivek T Humne
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Journal of Taibah University for Science
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/16583655.2024.2336674